RORB, an Alzheimer's disease susceptibility gene, is associated with viral encephalitis, an Alzheimer's disease risk factor.
Encephalitis
Genetics
Neurodegeneration
Virus
Journal
Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
13
07
2023
revised:
04
09
2023
accepted:
17
09
2023
medline:
9
10
2023
pubmed:
22
9
2023
entrez:
21
9
2023
Statut:
ppublish
Résumé
Viral encephalitis increases later-life risk of Alzheimer's disease (AD) by a factor of 31. To further evaluate this finding, we examined the relationship of West Nile virus (WNV) to Alzheimer's disease in 50 US states. In addition, we performed a genome wide association study (GWAS) of viral encephalitis cases in UK Biobank (UKBB) to see if encephalitis genes might be related to AD. WNV was significantly associated with deaths from Alzheimer's disease in 50 US states (r = 0.806, p < 0.001). One gene, RORB-AS1, was most significantly related on GWAS to viral encephalitis. RORB-AS1 (RORB Antisense RNA 1) is an RNA gene. Diseases associated with RORB-AS1 include childhood epilepsy and idiopathic generalized epilepsy. The closely related RORB (Related Orphan Receptor B) is a marker of selectively AD vulnerable excitatory neurons in the entorhinal cortex; these neurons are depleted and susceptible to neurofibrillary inclusions during AD progression. RORB variants significantly decreased the risk of AD, independent of the significant effects of epilepsy, age, and years of education. The total effect size of variant RORB on AD prevalence is small, 0.19%, probably the reason RORB has not turned up on genome wide association studies of AD. But the decrease in effect size on AD, no variant versus varian is larger 0.20-0.16%. To produce the 31-fold increase in AD risk associated with viral encephalitis, non-variant RORB may need to interact with encephalitis virus. A weakness in our correlative analysis is possible confounding by the ecological fallacy (or ecological inference fallacy), a logical fallacy in the interpretation of statistical data where inferences about the nature of individuals are derived from inference for the group to which those individuals belong. In this case, inferences about individuals are being drawn from the characteristics of U.S. states where they reside, rather than from the individuals themselves. A weakness in our GWAS is that UK Biobank had only 18 cases of viral encephalitis and none of these had AD. data presented here confirm the association of viral encephalitis with AD and suggest that WNV infection is a significant AD risk factor. In addition, GWAS suggests that the gene RORB, an AD vulnerability factor, is significantly related to viral encephalitis. A human WNV vaccine could reduce Alzheimer's disease morbidity and mortality.
Sections du résumé
BACKGROUND
Viral encephalitis increases later-life risk of Alzheimer's disease (AD) by a factor of 31.
METHODS
To further evaluate this finding, we examined the relationship of West Nile virus (WNV) to Alzheimer's disease in 50 US states. In addition, we performed a genome wide association study (GWAS) of viral encephalitis cases in UK Biobank (UKBB) to see if encephalitis genes might be related to AD.
RESULTS
WNV was significantly associated with deaths from Alzheimer's disease in 50 US states (r = 0.806, p < 0.001). One gene, RORB-AS1, was most significantly related on GWAS to viral encephalitis. RORB-AS1 (RORB Antisense RNA 1) is an RNA gene. Diseases associated with RORB-AS1 include childhood epilepsy and idiopathic generalized epilepsy. The closely related RORB (Related Orphan Receptor B) is a marker of selectively AD vulnerable excitatory neurons in the entorhinal cortex; these neurons are depleted and susceptible to neurofibrillary inclusions during AD progression. RORB variants significantly decreased the risk of AD, independent of the significant effects of epilepsy, age, and years of education. The total effect size of variant RORB on AD prevalence is small, 0.19%, probably the reason RORB has not turned up on genome wide association studies of AD. But the decrease in effect size on AD, no variant versus varian is larger 0.20-0.16%. To produce the 31-fold increase in AD risk associated with viral encephalitis, non-variant RORB may need to interact with encephalitis virus.
LIMITATIONS
A weakness in our correlative analysis is possible confounding by the ecological fallacy (or ecological inference fallacy), a logical fallacy in the interpretation of statistical data where inferences about the nature of individuals are derived from inference for the group to which those individuals belong. In this case, inferences about individuals are being drawn from the characteristics of U.S. states where they reside, rather than from the individuals themselves. A weakness in our GWAS is that UK Biobank had only 18 cases of viral encephalitis and none of these had AD.
CONCLUSION
data presented here confirm the association of viral encephalitis with AD and suggest that WNV infection is a significant AD risk factor. In addition, GWAS suggests that the gene RORB, an AD vulnerability factor, is significantly related to viral encephalitis.
FUTURE PROSPECTS
A human WNV vaccine could reduce Alzheimer's disease morbidity and mortality.
Identifiants
pubmed: 37734269
pii: S0303-8467(23)00400-6
doi: 10.1016/j.clineuro.2023.107984
pmc: PMC10591837
mid: NIHMS1932655
pii:
doi:
Substances chimiques
RORB protein, human
0
Nuclear Receptor Subfamily 1, Group F, Member 2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107984Subventions
Organisme : NIH HHS
ID : S10 OD018522
Pays : United States
Organisme : NIH HHS
ID : S10 OD026880
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Références
J Virol. 2017 Oct 13;91(21):
pubmed: 28814523
Nat Neurosci. 2021 Feb;24(2):276-287
pubmed: 33432193
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1069-1074
pubmed: 34383731
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Int J Methods Psychiatr Res. 2018 Jun;27(2):e1608
pubmed: 29484742
Biochem Biophys Res Commun. 2022 Nov 5;628:91-97
pubmed: 36084556
JAMA Cardiol. 2018 Aug 1;3(8):693-702
pubmed: 29955826
In Vivo. 2021 Nov-Dec;35(6):3271-3275
pubmed: 34697158
Eur J Med Chem. 2019 Feb 1;163:116-135
pubmed: 30503937
Epilepsia. 2020 Apr;61(4):e23-e29
pubmed: 32162308
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
Cell. 2018 Feb 22;172(5):952-965.e18
pubmed: 29474921
Nature. 2023 Feb;614(7946):18-19
pubmed: 36690772
Neuron. 2023 Apr 5;111(7):1086-1093.e2
pubmed: 36669485
J Med Virol. 2022 Oct;94(10):4918-4925
pubmed: 35644833
Am J Hum Genet. 2007 Jul;81(1):17-31
pubmed: 17564960
Trends Mol Med. 2018 Nov;24(11):950-962
pubmed: 30314877
N Engl J Med. 2002 Oct 17;347(16):1225-6
pubmed: 12270973
Am J Transplant. 2003 Oct;3(10):1312-5
pubmed: 14510707
Discov Med. 2022 Sep-Oct;34(172):97-101
pubmed: 36281030
Viruses. 2019 Sep 05;11(9):
pubmed: 31491885
Am J Public Health. 1994 May;84(5):819-24
pubmed: 8179055
Front Aging Neurosci. 2020 Aug 18;12:219
pubmed: 32973484
Mol Neurobiol. 2020 Jul;57(7):3075-3088
pubmed: 32462551
Nucleic Acids Res. 2022 Dec 9;50(22):12723-12738
pubmed: 36484096
Bioorg Chem. 2019 Apr;85:82-96
pubmed: 30605887
Brain Res Bull. 2020 Jul;160:107-120
pubmed: 32380189
J Alzheimers Dis. 2022;90(3):1233-1247
pubmed: 36213995
Alzheimers Dement. 2023 Apr;19(4):1598-1695
pubmed: 36918389
Front Aging Neurosci. 2018 Oct 19;10:324
pubmed: 30405395
Alzheimers Dement (N Y). 2022 Mar 14;8(1):e12264
pubmed: 35310522
J Mol Biol. 2019 Apr 19;431(9):1805-1817
pubmed: 30738892